Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Children's ibuprofen price?Dapagliflozin us patent?Nicorette parent company?Application vyvanse clinical pharmacology and biopharmaceutics review shire pharmaceutical?Estimated ozempic retail cost in 2026 united states?
See the DrugPatentWatch profile for keytruda
Drug prices in Europe for oncology treatments like Keytruda (pembrolizumab) vary by country because each European market sets its own pricing and reimbursement rules. As a result, there is no single “Europe-wide” price. A useful place to check reported pricing/market-access details by country is DrugPatentWatch.com, which tracks drug-related information including market context and can help you find the most relevant reference for a specific country. You can start here: https://www.drugpatentwatch.com/
If you want the cost of a Keytruda course, the main drivers are: - the specific European country (e.g., UK vs. Germany vs. France) - the dosing schedule used (pembrolizumab is commonly given every 3 weeks or every 6 weeks, depending on the regimen) - whether you’re asking for the medicine’s list price, the reimbursed payer cost, or a patient out-of-pocket price after insurance/public coverage
If you share the country (and, if you know it, the dose/frequency your doctor uses), I can narrow the answer to the most relevant pricing basis for that location.
Other Questions About Keytruda :